Loading clinical trials...
Loading clinical trials...
Randomized Trial of REVITALIZE: A Telehealth Intervention to Reduce Fatigue Interference Among Adults With Advanced Ovarian Cancer on PARP Inhibitors
Conditions
Interventions
REVITALIZE Intervention
Educational Materials
Locations
6
United States
University of Colorado Cancer Center-Anschutz
Aurora, Colorado, United States
University of Colorado Boulder
Boulder, Colorado, United States
Massachusetts General Hospital-Cancer Center
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Duke Cancer Center
Durham, North Carolina, United States
Start Date
March 17, 2025
Primary Completion Date
December 31, 2028
Completion Date
January 31, 2029
Last Updated
April 13, 2026
NCT06257264
NCT06964009
NCT05969860
NCT05005403
NCT06547840
NCT05735080
Lead Sponsor
Dana-Farber Cancer Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions